| RVTY |
Report |
Pro forma revenue |
IN-LINE |
pred ~$705M vs. cons $702.0M |
MEDIUM |
| RVTY |
Report |
Adjusted operating EPS |
BEAT |
pred ~$1.25 vs. cons $1.232 |
MEDIUM |
| RVTY |
Report |
Organic revenue growth |
BEAT |
pred ~3.0% vs. cons 1.8% |
MEDIUM |
| RVTY |
Guide |
FY26 pro forma revenue |
UNCHANGED |
guide $2.81B-$2.84B vs. cons $2.829B |
MEDIUM |
| RVTY |
Guide |
FY26 pro forma adjusted EPS |
UNCHANGED |
guide $5.20-$5.30 vs. cons $5.277 |
MEDIUM |
| RVTY |
Guide |
Q3 adjusted operating EPS |
LOWER |
guide ~$1.29-$1.31 vs. cons $1.323 |
LOW |
| RVTY |
Guide |
Q3 pro forma revenue |
UNCHANGED |
guide ~$680M-$690M vs. cons $687M |
LOW |
| RVTY |
Return |
Day-1 residual (stock − beta × S&P 500) |
-2.0% |
— |
LOW |
| RVTY |
Return |
5-day cumulative residual |
-4.5% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — lower Q3 outlook drives revisions |
LOW |